2014 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2014: 65 approvals, 0 patent expiries, 0 Phase 3 milestones.

20122013201420152016

FDA / EMA / MHRA approvals (65)

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.